サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1233540

動物向け調剤の世界市場：人獣共通感染症の増加や動物福祉に対する意識の高まりが市場成長のための有利な機会を生み出すと期待される

The increasing prevalence of zoonotic diseases and growing awareness of animal welfare is expected to create lucrative opportunities for the market to grow
出版日: | 発行: Persistence Market Research | ページ情報: 英文 250 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
動物向け調剤の世界市場：人獣共通感染症の増加や動物福祉に対する意識の高まりが市場成長のための有利な機会を生み出すと期待される
出版日: 2023年01月23日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の動物向け調剤の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、製品動向、価格分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション・開発動向

第4章 主な成功要因

  • 採用率- 主な統計
  • 規制シナリオ
  • 疾病疫学
  • 製品のUSP分析
  • PESTEL分析
  • ポーターの分析

第5章 市場の背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会分析

第6章 COVID-19危機分析

  • COVID-19と影響分析
  • 市場シナリオ

第7章 世界の動物向け調剤市場の需要分析・予測

  • 過去の市場分析
  • 現在および将来の市場分析・予測

第8章 世界の動物向け調剤市場の分析・予測：製品別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場分析・予測
    • CNS剤
    • 抗感染剤
    • ホルモン・代用品
    • 抗炎症剤
    • その他
  • 市場の魅力分析

第9章 世界の動物向け調剤市場の分析・予測：動物別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場分析・予測
    • コンパニオンアニマル
    • 家畜
  • 市場の魅力分析

第10章 世界の動物向け調剤市場の分析・予測：製剤別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場分析・予測
    • 経口剤
    • 注射剤
    • その他
  • 市場の魅力分析

第11章 世界の動物向け調剤市場の分析・予測：地域別

  • イントロダクション
  • 過去の市場分析
  • 現在および将来の市場分析・予測
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場の魅力分析

第12章 北米の動物向け調剤市場の分析・予測

第13章 ラテンアメリカの動物向け調剤市場の分析・予測

第14章 欧州の動物向け調剤市場の分析・予測

第15章 東アジアの動物向け調剤市場の分析・予測

第16章 南アジアの動物向け調剤市場の分析・予測

第17章 オセアニアの動物向け調剤市場の分析・予測

第18章 中東・アフリカの動物向け調剤市場の分析・予測

第19章 市場構造分析

  • 市場分析：企業ティア別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーキング
  • 競合ディープダイブ
    • Medisca Inc.
    • Hoye's Pharmacy
    • Vertisis Custom Pharmacy
    • Smith Caldwell Drug Store
    • Sixth Avenue Medical Pharmacy
    • Dougherty's Pharmacy
    • Triangle Compounding Pharmacy Inc.
    • Medisca Inc.
    • Wedgewood Pharmacy
    • Millers Pharmacy
    • Chiron Compounding Pharmacy
    • MEDS Canadian Compounding Pharmacy
    • Aurora Compounding
    • Pace Pharmacy
    • Victoria Compounding Pharmacy
    • Pratt's Compounding Pharmacy
    • People's Choice Pharmacy

第21章 仮定・頭字語

第22章 調査手法

図表

List of Tables

  • Table 01: Global Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033, by Product
  • Table 02: Global Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033by Animal
  • Table 03: Global Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033, by Formulation
  • Table 04: Global Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033, by Region
  • Table 05: North America Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Country
  • Table 06: North America Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Product
  • Table 07: North America Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Animal
  • Table 08: North America Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Formulation
  • Table 09: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Country
  • Table 10: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Product
  • Table 11: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Animal
  • Table 12: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Formulation
  • Table 13: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Country
  • Table 14: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Product
  • Table 15: Europe Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033by Animal
  • Table 16: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Formulation
  • Table 17: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Country
  • Table 18: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Product
  • Table 19: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Animal
  • Table 20: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Formulation
  • Table 21: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Country
  • Table 22: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Product
  • Table 23: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Animal
  • Table 24: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Formulation
  • Table 25: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Country
  • Table 26: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Product
  • Table 27: Oceania Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033by Animal
  • Table 28: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Formulation
  • Table 29: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Country
  • Table 30: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Product
  • Table 31: Middle East & Africa Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033by Animal
  • Table 32: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Formulation

List of Figures

  • Figure 01: Global Animal Drug Compounding Market Value (US$ Mn) Analysis, 2014-2022
  • Figure 02: Global Animal Drug Compounding Market Forecast & Y-o-Y Growth, 2023-2033
  • Figure 03: Global Animal Drug Compounding Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
  • Figure 04: Global Animal Drug Compounding Market Value Share (%) Analysis 2023 and 2033, by Product
  • Figure 05: Global Animal Drug Compounding Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
  • Figure 06: Global Animal Drug Compounding Market Attractiveness Analysis 2023-2033, by Product
  • Figure 07: Global Animal Drug Compounding Market Value Share (%) Analysis 2023 and 2033, by Animal
  • Figure 08: Global Animal Drug Compounding Market Y-o-Y Growth (%) Analysis 2022-2033, by Animal
  • Figure 09: Global Animal Drug Compounding Market Attractiveness Analysis 2023-2033, by Animal
  • Figure 10: Global Animal Drug Compounding Market Value Share (%) Analysis 2023 and 2033, by Formulation
  • Figure 11: Global Animal Drug Compounding Market Y-o-Y Growth (%) Analysis 2022-2033, by Formulation
  • Figure 12: Global Animal Drug Compounding Market Attractiveness Analysis 2023-2033, by Formulation
  • Figure 13: Global Animal Drug Compounding Market Value Share (%) Analysis 2023 and 2033, by Region
  • Figure 14: Global Animal Drug Compounding Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
  • Figure 15: Global Animal Drug Compounding Market Attractiveness Analysis 2023-2033, by Region
  • Figure 16: North America Animal Drug Compounding Market Value (US$ Mn) Analysis, 2014-2022
  • Figure 17: North America Animal Drug Compounding Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 18: North America Animal Drug Compounding Market Value Share, by Product (2023 E)
  • Figure 19: North America Animal Drug Compounding Market Value Share, by Animal (2023 E)
  • Figure 20: North America Animal Drug Compounding Market Value Share, by Formulation (2023 E)
  • Figure 21: North America Animal Drug Compounding Market Value Share, by Country (2023 E)
  • Figure 22: North America Animal Drug Compounding Market Attractiveness Analysis by Product, 2023-2033
  • Figure 23: North America Animal Drug Compounding Market Attractiveness Analysis by Animal, 2023-2033
  • Figure 24: North America Animal Drug Compounding Market Attractiveness Analysis by Formulation, 2023-2033
  • Figure 25: North America Animal Drug Compounding Market Attractiveness Analysis by Country, 2023-2033
  • Figure 26: U.S. Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 27: Global Vs. U.S. Growth Comparison
  • Figure 28: U.S. Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 29: U.S. Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 30: U.S. Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 31: Canada Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 32: Global Vs. Canada. Growth Comparison
  • Figure 33: Canada Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 34: Canada Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 35: Canada Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 36: Latin America Animal Drug Compounding Market Value (US$ Mn) Analysis, 2014-2022
  • Figure 37: Latin America Animal Drug Compounding Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 38: Latin America Animal Drug Compounding Market Value Share, by Product (2023 E)
  • Figure 39: Latin America Animal Drug Compounding Market Value Share, by Animal (2023 E)
  • Figure 40: Latin America Animal Drug Compounding Market Value Share, by Formulation (2023 E)
  • Figure 41: Latin America Animal Drug Compounding Market Value Share, by Country (2023 E)
  • Figure 42: Latin America Animal Drug Compounding Market Attractiveness Analysis by Product, 2023-2033
  • Figure 43: Latin America Animal Drug Compounding Market Attractiveness Analysis by Animal, 2023-2033
  • Figure 44: Latin America Animal Drug Compounding Market Attractiveness Analysis by Formulation, 2023-2033
  • Figure 45: Latin America Animal Drug Compounding Market Attractiveness Analysis by Country, 2023-2033
  • Figure 46: Mexico Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 47: Global Vs Mexico Growth Comparison
  • Figure 48: Mexico Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 49: Mexico Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 50: Mexico Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 51: Brazil Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 52: Global Vs. Brazil. Growth Comparison
  • Figure 53: Brazil Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 54: Brazil Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 55: Brazil Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 56: Argentina Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 57: Global Vs Argentina Growth Comparison
  • Figure 58: Argentina Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 59: Argentina Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 60: Argentina Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 61: Europe Animal Drug Compounding Market Value (US$ Mn) Analysis, 2014-2022
  • Figure 62: Europe Animal Drug Compounding Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 63: Europe Animal Drug Compounding Market Value Share, by Product (2023 E)
  • Figure 64: Europe Animal Drug Compounding Market Value Share, by Animal (2023 E)
  • Figure 65: Europe Animal Drug Compounding Market Value Share, by Formulation (2023 E)
  • Figure 66: Europe Animal Drug Compounding Market Value Share, by Country (2023 E)
  • Figure 67: Europe Animal Drug Compounding Market Attractiveness Analysis by Product, 2023-2033
  • Figure 68: Europe Animal Drug Compounding Market Attractiveness Analysis by Animal, 2023-2033
  • Figure 69: Europe Animal Drug Compounding Market Attractiveness Analysis by Formulation, 2023-2033
  • Figure 70: Europe Animal Drug Compounding Market Attractiveness Analysis by Country, 2023-2033
  • Figure 71: UK Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 72: Global Vs. UK Growth Comparison
  • Figure 73: UK Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 74: UK Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 75: UK Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 76: Germany Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 77: Global Vs. Germany Growth Comparison
  • Figure 78: Germany Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 79: Germany Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 80: Germany Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 81: Italy Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 82: Global Vs. Italy Growth Comparison
  • Figure 83: Italy Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 84: Italy Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 85: Italy Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 86: France Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 87: Global Vs France Growth Comparison
  • Figure 88: France Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 89: France Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 90: France Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 91: Spain Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 92: Global Vs Spain Growth Comparison
  • Figure 93: Spain Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 94: Spain Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 95: Spain Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 96: Russia Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 97: Global Vs Russia Growth Comparison
  • Figure 98: Russia Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 99: Russia Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 100: Russia Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 101: BENELUX Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 102: Global Vs BENELUX Growth Comparison
  • Figure 103: BENELUX Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 104: BENELUX Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 105: BENELUX Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 106: East Asia Animal Drug Compounding Market Value (US$ Mn) Analysis, 2014-2022
  • Figure 107: East Asia Animal Drug Compounding Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 108: East Asia Animal Drug Compounding Market Value Share, by Product (2023 E)
  • Figure 109: East Asia Animal Drug Compounding Market Value Share, by Animal (2023 E)
  • Figure 110: East Asia Animal Drug Compounding Market Value Share, by Formulation (2023 E)
  • Figure 111: East Asia Animal Drug Compounding Market Value Share, by Country (2023 E)
  • Figure 112: East Asia Animal Drug Compounding Market Attractiveness Analysis by Product, 2023-2033
  • Figure 113: East Asia Animal Drug Compounding Market Attractiveness Analysis by Animal, 2023-2033
  • Figure 114: East Asia Animal Drug Compounding Market Attractiveness Analysis by Formulation, 2023-2033
  • Figure 115: East Asia Animal Drug Compounding Market Attractiveness Analysis by Country, 2023-2033
  • Figure 116: China Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 117: Global Vs. China Growth Comparison
  • Figure 118: China Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 119: China Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 120: China Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 121: Japan Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 122: Global Vs. Japan Growth Comparison
  • Figure 123: Japan Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 124: Japan Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 125: Japan Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 126: South Korea Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 127: Global Vs South Korea Growth Comparison
  • Figure 128: South Korea Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 129: South Korea Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 130: South Korea Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 131: South Asia Animal Drug Compounding Market Value (US$ Mn) Analysis, 2014-2022
  • Figure 132: South Asia Animal Drug Compounding Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 133: South Asia Animal Drug Compounding Market Value Share, by Product (2023 E)
  • Figure 134: South Asia Animal Drug Compounding Market Value Share, by Animal (2023 E)
  • Figure 135: South Asia Animal Drug Compounding Market Value Share, by Formulation (2023 E)
  • Figure 136: South Asia Animal Drug Compounding Market Value Share, by Country (2023 E)
  • Figure 137: South Asia Animal Drug Compounding Market Attractiveness Analysis by Product, 2023-2033
  • Figure 138: South Asia Animal Drug Compounding Market Attractiveness Analysis by Animal, 2023-2033
  • Figure 139: South Asia Animal Drug Compounding Market Attractiveness Analysis by Formulation, 2023-2033
  • Figure 140: South Asia Animal Drug Compounding Market Attractiveness Analysis by Country, 2023-2033
  • Figure 141: India Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 142: Global Vs. India Growth Comparison
  • Figure 143: India Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 144: India Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 145: India Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 146: Indonesia Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 147: Global Vs. Indonesia Growth Comparison
  • Figure 148: Indonesia Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 149: Indonesia Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 150: Indonesia Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 151: Malaysia Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 152: Global Vs. Malaysia Growth Comparison
  • Figure 153: Malaysia Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 154: Malaysia Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 155: Malaysia Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 156: Thailand Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 157: Global Vs. Thailand Growth Comparison
  • Figure 158: Thailand Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 159: Thailand Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 160: Thailand Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 161: Oceania Animal Drug Compounding Market Value (US$ Mn) Analysis, 2014-2022
  • Figure 162: Oceania Animal Drug Compounding Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 163: Oceania Animal Drug Compounding Market Value Share, by Product (2023 E)
  • Figure 164: Oceania Animal Drug Compounding Market Value Share, by Animal (2023 E)
  • Figure 165: Oceania Animal Drug Compounding Market Value Share, by Formulation (2023 E)
  • Figure 166: Oceania Animal Drug Compounding Market Value Share, by Country (2023 E)
  • Figure 167: Oceania Animal Drug Compounding Market Attractiveness Analysis by Product, 2023-2033
  • Figure 168: Oceania Animal Drug Compounding Market Attractiveness Analysis by Animal, 2023-2033
  • Figure 169: Oceania Animal Drug Compounding Market Attractiveness Analysis by Formulation, 2023-2033
  • Figure 170: Oceania Animal Drug Compounding Market Attractiveness Analysis by Country, 2023-2033
  • Figure 171: Australia Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 172: Global Vs. Australia Growth Comparison
  • Figure 173: Australia Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 174: Australia Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 175: Australia Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 176: New Zealand Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 177: Global Vs New Zealand Growth Comparison
  • Figure 178: New Zealand Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 179: New Zealand Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 180: New Zealand Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 181: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Analysis, 2014-2022
  • Figure 182: Middle East & Africa Animal Drug Compounding Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 183: Middle East & Africa Animal Drug Compounding Market Value Share, by Product (2023 E)
  • Figure 184: Middle East & Africa Animal Drug Compounding Market Value Share, by Animal (2023 E)
  • Figure 185: Middle East & Africa Animal Drug Compounding Market Value Share, by Formulation (2023 E)
  • Figure 186: Middle East & Africa Animal Drug Compounding Market Value Share, by Country (2023 E)
  • Figure 187: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis by Product, 2023-2033
  • Figure 188: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis by Animal, 2023-2033
  • Figure 189: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis by Formulation, 2023-2033
  • Figure 190: Middle East & Africa Animal Drug Compounding Market Attractiveness Analysis by Country, 2023-2033
  • Figure 191: GCC Countries Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 192: Global Vs GCC Countries Growth Comparison
  • Figure 193: GCC Countries Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 194: GCC Countries Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 195: GCC Countries Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 196: Turkey Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 197: Global Vs. Turkey Growth Comparison
  • Figure 198: Turkey Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 199: Turkey Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 200: Turkey Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 201: South Africa Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 202: Global Vs. South Africa Growth Comparison
  • Figure 203: South Africa Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 204: South Africa Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 205: South Africa Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
  • Figure 206: North Africa Animal Drug Compounding Market Value Proportion Analysis, 2022
  • Figure 207: Global Vs North Africa Growth Comparison
  • Figure 208: North Africa Animal Drug Compounding Market Share Analysis (%) by Product, 2022 & 2033
  • Figure 209: North Africa Animal Drug Compounding Market Share Analysis (%) by Animal, 2022 & 2033
  • Figure 210: North Africa Animal Drug Compounding Market Share Analysis (%) by Formulation, 2022 & 2033
目次
Product Code: PMRREP12871

Animal Drug Compounding Market: Scope of Report

The latest publication by Persistence Market Research on the global animal drug compounding market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers in knowing the demand for animal drug compounding and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the animal drug compounding market. Shareholders in the animal drug compounding market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the animal drug compounding market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the animal drug compounding market offers information divided into four important segments - product, animal, formulation, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

CNS Agents

Anti-Infective Agents

Hormones and Substitutes

Anti-inflammatory Agents

Others

Animal

Companion Animal

Cats

Dogs

Others

Livestock Animals

Formulation

Oral

Injectable

Others

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle-East & Africa

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for animal drug compounding over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the animal drug compounding market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the animal drug compounding market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the animal drug compounding market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmaps
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate - Key Statistics
  • 4.2. Regulatory Scenario
  • 4.3. Disease Epidemiology
  • 4.4. Product USP Analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Compounding Pharmacies Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Zoonotic Disease
    • 5.2.2. Growing Awareness of Veterinary Compounded Medications
    • 5.2.3. Rising Demand of Animal Compounded Drugs
    • 5.2.4. Increasing Pet Ownerships
    • 5.2.5. Less Availability of Licensed/Branded Medications
    • 5.2.6. Greater Adoption of Flavor Enhanced Medicines
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Animal
    • 6.1.3. By Formulation
    • 6.1.4. By Region
  • 6.2. 2021 Market Scenario

7. Global Animal Drug Compounding Market Demand (in Value US$ Mn) Analysis 2014-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2014-2022
  • 7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis, by Product, 2014-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2023-2033
    • 8.3.1. CNS Agents
    • 8.3.2. Anti-Infective Agents
    • 8.3.3. Hormones and Substitutes
    • 8.3.4. Anti-inflammatory Agents
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis, by Product

9. Global Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033, By Animal

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Animal, 2014-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Animal, 2023-2033
    • 9.3.1. Companion Animal
      • 9.3.1.1. Cats
      • 9.3.1.2. Dogs
      • 9.3.1.3. Others
    • 9.3.2. Livestock Animals
  • 9.4. Market Attractiveness Analysis, by Animal

10. Global Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033, By Formulation

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Formulation, 2014-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Formulation, 2023-2033
    • 10.3.1. Oral
    • 10.3.2. Injectable
    • 10.3.3. Others
  • 10.4. Market Attractiveness Analysis, by Formulation

11. Global Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2014-2022
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Animal
    • 12.3.4. By Formulation
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Animal
    • 12.4.4. By Formulation
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Animal Drug Compounding Market Analysis
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.1.2.1. By Product
        • 12.7.1.2.2. By Animal
        • 12.7.1.2.3. By Formulation
    • 12.7.2. Canada Animal Drug Compounding Market Analysis
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.2.2.1. By Product
        • 12.7.2.2.2. By Animal
        • 12.7.2.2.3. By Formulation

13. Latin America Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Animal
    • 13.3.4. By Formulation
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Animal
    • 13.4.4. By Formulation
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Mexico Animal Drug Compounding Market Analysis
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.1.2.1. By Product
        • 13.7.1.2.2. By Animal
        • 13.7.1.2.3. By Formulation
    • 13.7.2. Brazil Animal Drug Compounding Market Analysis
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.2.2.1. By Product
        • 13.7.2.2.2. By Animal
        • 13.7.2.2.3. By Formulation
    • 13.7.3. Argentina Animal Drug Compounding Market Analysis
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.3.2.1. By Product
        • 13.7.3.2.2. By Animal
        • 13.7.3.2.3. By Formulation

14. Europe Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Animal
    • 14.3.4. By Formulation
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Animal
    • 14.4.4. By Formulation
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Animal Drug Compounding Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Animal
        • 14.7.1.2.3. By Formulation
    • 14.7.2. Italy Animal Drug Compounding Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Animal
        • 14.7.2.2.3. By Formulation
    • 14.7.3. France Animal Drug Compounding Market Analysis
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.3.2.1. By Product
        • 14.7.3.2.2. By Animal
        • 14.7.3.2.3. By Formulation
    • 14.7.4. U.K. Animal Drug Compounding Market Analysis
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.4.2.1. By Product
        • 14.7.4.2.2. By Animal
        • 14.7.4.2.3. By Formulation
    • 14.7.5. Spain Animal Drug Compounding Market Analysis
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.5.2.1. By Product
        • 14.7.5.2.2. By Animal
        • 14.7.5.2.3. By Formulation
    • 14.7.6. BENELUX Animal Drug Compounding Market Analysis
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.6.2.1. By Product
        • 14.7.6.2.2. By Animal
        • 14.7.6.2.3. By Formulation
    • 14.7.7. Russia Animal Drug Compounding Market Analysis
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.7.2.1. By Product
        • 14.7.7.2.2. By Animal
        • 14.7.7.2.3. By Formulation

15. East Asia Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Formulation (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Animal
    • 15.3.4. By Formulation
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product
    • 15.4.2. By Animal
    • 15.4.3. By Formulation
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. China Animal Drug Compounding Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Animal
        • 15.7.1.2.3. By Formulation
    • 15.7.2. Japan Animal Drug Compounding Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Animal
        • 15.7.2.2.3. By Formulation
    • 15.7.3. South Korea Animal Drug Compounding Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Animal
        • 15.7.3.2.3. By Formulation

16. South Asia Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Animal
    • 16.3.4. By Formulation
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Animal
    • 16.4.4. By Formulation
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. India Animal Drug Compounding Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Animal
        • 16.7.1.2.3. By Formulation
    • 16.7.2. Indonesia Animal Drug Compounding Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Animal
        • 16.7.2.2.3. By Formulation
    • 16.7.3. Malaysia Animal Drug Compounding Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Animal
        • 16.7.3.2.3. By Formulation
    • 16.7.4. Thailand Animal Drug Compounding Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Animal
        • 16.7.4.2.3. By Formulation

17. Oceania Animal Drug Compounding Market 2012-2021 and Forecast 2022-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Animal
    • 17.3.4. By Formulation
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Animal
    • 17.4.4. By Formulation
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Animal Drug Compounding Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Animal
        • 17.7.1.2.3. By Formulation
    • 17.7.2. New Zealand Animal Drug Compounding Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Animal
        • 17.7.2.2.3. By Formulation

18. Middle East and Africa (MEA) Animal Drug Compounding Market Analysis 2014-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022
  • 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Animal
    • 18.3.4. By Formulation
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Animal
    • 18.4.3. By Formulation
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Animal Drug Compounding Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Animal
        • 18.7.1.2.3. By Formulation
    • 18.7.2. Turkey Animal Drug Compounding Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Animal
        • 18.7.2.2.3. By Formulation
    • 18.7.3. South Africa Animal Drug Compounding Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Animal
        • 18.7.3.2.3. By Formulation
    • 18.7.4. North Africa Animal Drug Compounding Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Animal
        • 18.7.4.2.3. By Formulation

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Medisca Inc.
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. Hoye's Pharmacy
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Product Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Vertisis Custom Pharmacy
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Product Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Smith Caldwell Drug Store
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Product Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. Sixth Avenue Medical Pharmacy
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Product Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. Dougherty's Pharmacy
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Product Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. Triangle Compounding Pharmacy Inc.
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Product Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. Medisca Inc.
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Product Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Wedgewood Pharmacy
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Product Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. Millers Pharmacy
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Product Strategy
        • 20.3.10.6.3. Channel Strategy
    • 20.3.11. Chiron Compounding Pharmacy
      • 20.3.11.1. Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Sales Footprint
      • 20.3.11.4. Key Financials
      • 20.3.11.5. SWOT Analysis
      • 20.3.11.6. Strategy Overview
        • 20.3.11.6.1. Marketing Strategy
        • 20.3.11.6.2. Product Strategy
        • 20.3.11.6.3. Channel Strategy
    • 20.3.12. MEDS Canadian Compounding Pharmacy
      • 20.3.12.1. Overview
      • 20.3.12.2. Product Portfolio
      • 20.3.12.3. Sales Footprint
      • 20.3.12.4. Key Financials
      • 20.3.12.5. SWOT Analysis
      • 20.3.12.6. Strategy Overview
        • 20.3.12.6.1. Marketing Strategy
        • 20.3.12.6.2. Product Strategy
        • 20.3.12.6.3. Channel Strategy
    • 20.3.13. Aurora Compounding
      • 20.3.13.1. Overview
      • 20.3.13.2. Product Portfolio
      • 20.3.13.3. Sales Footprint
      • 20.3.13.4. Key Financials
      • 20.3.13.5. SWOT Analysis
      • 20.3.13.6. Strategy Overview
        • 20.3.13.6.1. Marketing Strategy
        • 20.3.13.6.2. Product Strategy
        • 20.3.13.6.3. Channel Strategy
    • 20.3.14. Pace Pharmacy
      • 20.3.14.1. Overview
      • 20.3.14.2. Product Portfolio
      • 20.3.14.3. Sales Footprint
      • 20.3.14.4. Key Financials
      • 20.3.14.5. SWOT Analysis
      • 20.3.14.6. Strategy Overview
        • 20.3.14.6.1. Marketing Strategy
        • 20.3.14.6.2. Product Strategy
        • 20.3.14.6.3. Channel Strategy
    • 20.3.15. Victoria Compounding Pharmacy
      • 20.3.15.1. Overview
      • 20.3.15.2. Product Portfolio
      • 20.3.15.3. Sales Footprint
      • 20.3.15.4. Key Financials
      • 20.3.15.5. SWOT Analysis
      • 20.3.15.6. Strategy Overview
        • 20.3.15.6.1. Marketing Strategy
        • 20.3.15.6.2. Product Strategy
        • 20.3.15.6.3. Channel Strategy
    • 20.3.16. Pratt's Compounding Pharmacy
      • 20.3.16.1. Overview
      • 20.3.16.2. Product Portfolio
      • 20.3.16.3. Sales Footprint
      • 20.3.16.4. Key Financials
      • 20.3.16.5. SWOT Analysis
      • 20.3.16.6. Strategy Overview
        • 20.3.16.6.1. Marketing Strategy
        • 20.3.16.6.2. Product Strategy
        • 20.3.16.6.3. Channel Strategy
    • 20.3.17. People's Choice Pharmacy
      • 20.3.17.1. Overview
      • 20.3.17.2. Product Portfolio
      • 20.3.17.3. Sales Footprint
      • 20.3.17.4. Key Financials
      • 20.3.17.5. SWOT Analysis
      • 20.3.17.6. Strategy Overview
        • 20.3.17.6.1. Marketing Strategy
        • 20.3.17.6.2. Product Strategy
        • 20.3.17.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology